An additional cause of prescribing error

摘要

I would like to add another category of error to the helpful description given by Slight and colleagues. A patient of mine was approached to take part in a trial of medication: the REVEAL study (http://www.ctsu.ox.ac.uk/~reveal/). This seeks to test a new drug, anacetrapib, in the context of lipid lowering. The paperwork was scanned into our EMIS Web system and I reviewed the letter. The EMIS prescribing module allows 'red' drugs to be included in the prescribing record so that possible interactions with proposed new medication is highlighted.